End-of-Life Psychological Distress: Psychedelics have been effectively used to reduce psychological distress in terminal patients, helping them to face death with a greater sense of peace.
Enhanced Creativity: Some studies and anecdotal reports suggest that psychedelics can enhance creativity, making them a tool of interest for artists and other creative professionals.
Increased Openness: Following psychedelic use, individuals may experience increased openness-an aspect of personality associated with openness to new experiences, broad-mindedness, and creativity-which can last for several months or even longer.
PTSD Treatment: MDMA, commonly known as ecstasy, has been studied for its effectiveness in treating post-traumatic stress disorder (PTSD) and has been granted breakthrough therapy designation by the FDA for this purpose.
Treatment of Depression: Clinical trials have shown that psychedelics like psilocybin can produce significant reductions in depression symptoms, often with single doses having long-lasting effects.